STAA - スタ―サ―ジカル (STAAR Surgical Company) スタ―サ―ジカル



symbol STAA
会社名 Staar Surgical Co. (スタ―サ―ジカル)
分野(sector) Health Care   ヘルスケア
産業(industry) Ophthalmic Goods  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 スター・サージカル(STAAR Surgical Company)は、眼科用移植型レンズ及び眼内にレンズを送達するために使用される送達システムを設計・開発・生産・販売している。同社は眼手術市場セグメントで事業を展開する。主な製品は、白内障手術に使用される眼内レンズと、屈折矯正手術で使用される埋め込み型コラーマーレンズである。同社は、矯正手術と屈折矯正手術で世界中で使用されているレンズを作り、白内障を治療する手術で使用するレンズを作る。その屈折矯正手術は、眼鏡またはコンタクトレンズが治療している視覚障害(近視、遠視、乱視および老視)のタイプを矯正する。同社は米国、カナダ、日本、スペインでの直接販売、世界の残りの地域での独立した販売など、75カ国以上で製品を販売している。   スタ―サ―ジカルは、眼内に移植可能なレンズを開発、製造、販売する米国の会社。矯正や屈折矯正手術で使用されるレンズのメ―カ―である。白内障を治療する手術に使用するためのレンズも製造。同社が開発するすべてのレンズは折りたたみ可能で、手術の際、小さな切開部からも挿入可能である。主要製品のブランド名は、「STAAR」「Collamer」など。   STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.
本社所在地 1911 Walker Avenue Monrovia CA 91016 USA
代表者氏名 Louis E. Silverman ルイE.シルバーマン
代表者役職名 Independent Chairman of the Board
電話番号 +1 626-303-7902
設立年月日 30225
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 353人
EBITDA EBITDA(百万ドル) 6.48900
終値(lastsale) 41.54
時価総額(marketcap) 1825489215.9
時価総額 時価総額(百万ドル) 1770.969
売上高 売上高(百万ドル) 109.32300
企業価値(EV) 企業価値(EV)(百万ドル) 1756.707
当期純利益 当期純利益(百万ドル) 9.10600
決算概要 決算概要 BRIEF: For the six months ended 29 June 2018 STAAR Surgical Company revenues increased 44% to $61M. Net income totaled $2.4M vs. loss of $3.2M. Revenues reflect China segment increase from $10.3M to $21.9M Others segment increase of 28% to $23.4M. Net Income reflects Royalty income increase of 18% to $306K (income) Interest expense decrease of 40% to $36K (expense).



   Intraocular Lens Market Generated Opportunities, Future Scope 2021-2028 | STAAR Surgical Company, HOYA Corporation, Lenstec, Inc.  2021/12/24 07:53:54 OpenPR
Another factual information on the "Intraocular Lens Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall
   Stephens Inc. AR Sells 1,712 Shares of STAAR Surgical (NASDAQ:STAA)  2021/12/22 09:40:45 Dakota Financial News
Stephens Inc. AR trimmed its holdings in shares of STAAR Surgical (NASDAQ:STAA) by 23.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,636 shares of the medical instruments suppliers stock after selling 1,712 shares during the period. Stephens Inc. ARs holdings in []
   Strs Ohio Reduces Stake in STAAR Surgical (NASDAQ:STAA)  2021/12/18 10:04:41 Dakota Financial News
Strs Ohio trimmed its stake in STAAR Surgical (NASDAQ:STAA) by 21.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,200 shares of the medical instruments suppliers stock after selling 3,400 shares during the quarter. Strs Ohios holdings in STAAR []
   $59.30 Million in Sales Expected for STAAR Surgical (NASDAQ:STAA) This Quarter  2021/12/15 03:16:42 Transcript Daily
Equities analysts expect STAAR Surgical (NASDAQ:STAA) to report sales of $59.30 million for the current quarter, Zacks reports. Three analysts have made estimates for STAAR Surgicals earnings, with estimates ranging from $59.10 million to $59.40 million. STAAR Surgical posted sales of $46.00 million during the same quarter last year, which suggests a positive year-over-year growth []
   STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday Sells 6,000 Shares  2021/12/15 01:50:43 Transcript Daily
STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday sold 6,000 shares of the firms stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $89.57, for a total transaction of $537,420.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Shares of []
   STAAR Surgical Company (NASDAQ: STAA): Aiming For A Higher Share Price  2021/11/06 15:00:00 Stocks Register
STAAR Surgical Company (NASDAQ:STAA) shares, rose in value on Friday, 11/05/21, with the stock price down by -1.31% to the previous days close as strong demand from buyers drove the stock to $115.59. Actively observing the price movement in the last trading, the stock closed the session at $117.12, falling within a range of $109.13 STAAR Surgical Company (NASDAQ: STAA): Aiming For A Higher Share Price Read More »
   STAAR Surgical Company (STAA) Q3 2021 Earnings Call Transcript  2021/11/04 03:31:29 The Motley Fool
STAA earnings call for the period ending September 30, 2021.
   STAAR Surgical EPS beats by $0.04, misses on revenue  2021/11/03 20:04:24 Seeking Alpha
   Zacks: Analysts Expect STAAR Surgical (NASDAQ:STAA) Will Post Earnings of $0.16 Per Share  2021/10/28 07:46:44 Transcript Daily
Wall Street brokerages expect STAAR Surgical (NASDAQ:STAA) to post $0.16 earnings per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for STAAR Surgicals earnings, with the lowest EPS estimate coming in at $0.15 and the highest estimate coming in at $0.17. STAAR Surgical posted earnings per share of $0.14 []
   Ocular Implant Market Detailed In New Research Report 2021 | Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services  2021/10/28 07:04:46 OpenPR
Ocular implants are medical instruments that are designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to enhance facial lineaments
   Is It Too Late to Buy Staar Surgical Stock?  2021/06/15 10:25:00 The Motley Fool
This company''s eye-opening surge has people wondering if it''s too late to get in on the boom.
   Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Collegium Pharmaceutical (COLL)  2021/06/04 12:45:08 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Staar Surgical Company (STAA) and The post Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Collegium Pharmaceutical (COLL) appeared first on Smarter Analyst .
   Is STAAR Surgical a Warren Buffett Stock?  2021/06/02 11:01:00 The Motley Fool
He''d appreciate its margins and its moat.
   Foldable Intraocular Lens Market: 3 Bold Projections 2021 | Watch How Big Opportunities Rising Till 2028 : Carl Zeiss Meditec, Hoya Corporation, Staar Surgical Company, Rayner Intraocular Lenses & More  2021/05/27 15:29:36 OpenPR
Worldwide Foldable Intraocular Lens Market Analysis to 2027 is a specialized and in-depth study of the Foldable Intraocular Lens Market Industry with a focus on the global market trend. The report aims to provide an overview of global Foldable Intraocular
   Palo Alto Investors, LLC Buys eHealth Inc, Biogen Inc, Gritstone Bio Inc, Sells Staar Surgical ...  2021/05/19 00:38:28 GuruFocus
Related Stocks: EHTH , BIIB , FOLD , ALKS , GRTS , MRNS , SYRS , APRE , SNSS ,

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 スタ―サ―ジカル STAA STAAR Surgical Company)


 twitter  (公式ツイッターやCEOツイッターなど)